Skip Nav Destination
Issues
Hypoglycemia and driving performance.
Diabetes Care February 2000, Vol.23, 148-150. doi:https://doi.org/10.2337/diacare.23.2.148
Isotypes of anti-islet autoantibodies.
Diabetes Care February 2000, Vol.23, 151-152. doi:https://doi.org/10.2337/diacare.23.2.151
Can medication packaging improve glycemic control and blood pressure in type 2 diabetes? Results from a randomized controlled trial.
Diabetes Care February 2000, Vol.23, 153-156. doi:https://doi.org/10.2337/diacare.23.2.153
Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes.
Diabetes Care February 2000, Vol.23, 157-162. doi:https://doi.org/10.2337/diacare.23.2.157
Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction.
Diabetes Care February 2000, Vol.23, 163-170. doi:https://doi.org/10.2337/diacare.23.2.163
Prevalence of undiagnosed diabetes in three American Indian populations. A comparison of the 1997 American Diabetes Association diagnostic criteria and the 1985 World Health Organization diagnostic criteria: the Strong Heart Study.
Diabetes Care February 2000, Vol.23, 181-186. doi:https://doi.org/10.2337/diacare.23.2.181
Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.
C L Rohlfing; R R Little; H M Wiedmeyer; J D England; R Madsen; M I Harris; K M Flegal; M S Eberhardt; D E Goldstein
Diabetes Care February 2000, Vol.23, 187-191. doi:https://doi.org/10.2337/diacare.23.2.187
Evaluation of the effect of performance monitoring and feedback on care process, utilization, and outcome.
Diabetes Care February 2000, Vol.23, 192-196. doi:https://doi.org/10.2337/diacare.23.2.192
Major stressful life events in relation to prevalence of undetected type 2 diabetes: the Hoorn Study.
Diabetes Care February 2000, Vol.23, 197-201. doi:https://doi.org/10.2337/diacare.23.2.197
Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.
Diabetes Care February 2000, Vol.23, 202-207. doi:https://doi.org/10.2337/diacare.23.2.202
A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration.
Diabetes Care February 2000, Vol.23, 208-214. doi:https://doi.org/10.2337/diacare.23.2.208
Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes.
Diabetes Care February 2000, Vol.23, 215-220. doi:https://doi.org/10.2337/diacare.23.2.215
Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.
Diabetes Care February 2000, Vol.23, 221-227. doi:https://doi.org/10.2337/diacare.23.2.221
Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality.
Diabetes Care February 2000, Vol.23, 228-233. doi:https://doi.org/10.2337/diacare.23.2.228
Serum markers of oxidative stress and severity of diabetic retinopathy.
Diabetes Care February 2000, Vol.23, 234-240. doi:https://doi.org/10.2337/diacare.23.2.234
Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis.
Diabetes Care February 2000, Vol.23, 241-247. doi:https://doi.org/10.2337/diacare.23.2.241
American Diabetes Association Annual Meeting, 1999: insulin action and the development of type 2 diabetes.
Diabetes Care February 2000, Vol.23, 248-252. doi:https://doi.org/10.2337/diacare.23.2.248
Plasma adrenomedullin levels in patients with diabetes.
Diabetes Care February 2000, Vol.23, 253-254. doi:https://doi.org/10.2337/diacare.23.2.253
Differential antioxidant status among Indo-Asians compared with caucasians with and without diabetes. Wolverhampton Diabetes Research Group.
Diabetes Care February 2000, Vol.23, 254-255. doi:https://doi.org/10.2337/diacare.23.2.254
The Batista procedure significantly improved cardiac function and glycemic control in a diabetic patient with severe insulin resistance.
Diabetes Care February 2000, Vol.23, 255-256. doi:https://doi.org/10.2337/diacare.23.2.255
Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes.
Diabetes Care February 2000, Vol.23, 256-258. doi:https://doi.org/10.2337/diacare.23.2.256
Lamin A/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy and insulin resistance.
Diabetes Care February 2000, Vol.23, 258-259. doi:https://doi.org/10.2337/diacare.23.2.258
Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients.
Diabetes Care February 2000, Vol.23, 259. doi:https://doi.org/10.2337/diacare.23.2.259
Contribution of abnormalities of thyroid hormones to type 2 diabetes.
Diabetes Care February 2000, Vol.23, 260-261. doi:https://doi.org/10.2337/diacare.23.2.260a
MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients.
Diabetes Care February 2000, Vol.23, 260. doi:https://doi.org/10.2337/diacare.23.2.260b
